News
18h
Zacks Investment Research on MSNKRYS Up 4% on Initiating Dosing in Rare Eye Disease Phase III StudyShares of Krystal Biotech KRYS gained 4.2% on Tuesday after the company announced that it has dosed the first patient in the ...
14h
CNET on MSN10 Tips to Keep Your Eyes Healthy As You AgeYou might be used to slathering on sunscreen to protect your skin, but have you been protecting your eyes as well? We only ...
22h
GlobalData on MSNStuart reports initial outcomes from trial of ophthalmic solution for DEDStuart Therapeutics has reported initial findings from its 29-day randomised Phase III trial of the ST-100 (vezocolmitide) ophthalmic solution for treating dry eye disease (DED). The ...
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today ...
Bonnie and John Buhler’s journey with and support of Misericordia Health Centre (MHC) dates back decades. Bonnie’s parents ...
The enforcement action in Singapore was part of Operation Pangea, which Interpol coordinated. Read more at straitstimes.com.
Regulatory Clearances Support Glaukos' Plans to Advance and Accelerate its Interventional Glaucoma Initiatives Globally Marks ...
A combination of genetics and drinking instant coffee is linked to an increased risk of developing a common form of ...
5h
News Medical on MSNUnknown organelle discovery could open the door to new treatments for inherited diseasesThe discovery of an unknown organelle inside our cells could open the door to new treatments for devastating inherited diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results